KKR Is Said to Consider Selling $750 Million Stake in JB Pharma
- US private equity firm working with investment bank on deal
- Size of potential block trade could increase based on demand
This article is for subscribers only.
KKR & Co. is considering selling some of its controlling stake in JB Chemicals & Pharmaceuticals Ltd. via a block trade in the market, according to people familiar with the matter.
The US private equity firm is working with an investment bank as it considers selling about $750 million worth of stock in the Indian-listed company known as JB Pharma, the people said, asking not to be identified because the matter is private. The size of the stake sale could be increased to $1 billion based on investor demand, the people said.